Serotonin, Synapses, and Setting: Gitte Moos Knudsen on the Neurobiology of Psychedelic Action By Watertime - March 30, 2026 9 Post Content RELATED ARTICLESMORE FROM AUTHOR A Practitioner Statement on the Responsible Development of Ibogaine in the United States – Open Letter Dr. Michael Alpert and Peter Alberding – ALS, Existential Distress, and Ketamine Therapy Pα+ Psychedelic Bulletin #223: Ibogaine Advocates Court Trump, via Rogan; Compass Launches Provider Training Grants; Therapeutic Alliance Debate Reignites
